Nirsevimab-resistant respiratory syncytial virus strains are rare but there

Mark E Peeples¹, Ilada Thongpan²

Affiliations

¹ Abigail Wexner Research Institute at Nationwide Children's Hospital, Center for Vaccines and Immunity, Columbus, OH 43205, USA; Infectious Disease Institute, The Ohio State University, Columbus, OH, USA. Electronic address: mark.peeples@nationwidechildrens.org.
² Abigail Wexner Research Institute at Nationwide Children's Hospital, Center for Vaccines and Immunity, Columbus, OH 43205, USA.

PMID: 36940704
DOI: 10.1016/S1473-3099(23)00137-8

Comment

Nirsevimab-resistant respiratory syncytial virus strains are rare but there

Mark E Peeples et al. Lancet Infect Dis. 2023 Jul.

. 2023 Jul;23(7):773-774.

doi: 10.1016/S1473-3099(23)00137-8. Epub 2023 Mar 17.

Authors

Mark E Peeples¹, Ilada Thongpan²

Affiliations

¹ Abigail Wexner Research Institute at Nationwide Children's Hospital, Center for Vaccines and Immunity, Columbus, OH 43205, USA; Infectious Disease Institute, The Ohio State University, Columbus, OH, USA. Electronic address: mark.peeples@nationwidechildrens.org.
² Abigail Wexner Research Institute at Nationwide Children's Hospital, Center for Vaccines and Immunity, Columbus, OH 43205, USA.

PMID: 36940704
DOI: 10.1016/S1473-3099(23)00137-8

No abstract available

PubMed Disclaimer

Conflict of interest statement

MEP has received NIH grant funding (grant numbers: R01 AI093848 and AI090060; P01 AI112524; and U19 AI42733), NIH Contract funding (DMID Protocol #20-0035), contract funding from Janssen, CyanVac/Blue Lake Biotechnology, and consulting fees from Merck outside of this work. IT declares no competing interests.

Comment on

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data.
Wilkins D, Langedijk AC, Lebbink RJ, Morehouse C, Abram ME, Ahani B, Aksyuk AA, Baraldi E, Brady T, Chen AT, Chi H, Choi EH, Cohen R, Danilenko DM, Gopalakrishnan V, Greenough A, Heikkinen T, Hosoya M, Keller C, Kelly EJ, Kragten-Tabatabaie L, Martinón-Torres F, de Los Santos AHM, Nunes MC, Palomino MA, Papenburg J, Pernica JM, Richmond P, Stein RT, Tuffy KM, Verwey C, Esser MT, Tabor DE, Bont LJ; INFORM-RSV Study Group. Wilkins D, et al. Lancet Infect Dis. 2023 Jul;23(7):856-866. doi: 10.1016/S1473-3099(23)00062-2. Epub 2023 Mar 17. Lancet Infect Dis. 2023. PMID: 36940703

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Nirsevimab-resistant respiratory syncytial virus strains are rare but there

Affiliations

Nirsevimab-resistant respiratory syncytial virus strains are rare but there

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical